Catching up with Dr. Mario Maldonado: milder hypercortisolism, AI, and what’s ahead

September 22, 2026

In this episode, Dr. Mario Maldonado from Recordati Rare Diseases discusses recent advances in endocrinology, focusing on hypercortisolism, diagnostic challenges, and innovative treatments. He shares insights from clinical studies and the future of AI in disease management.  We touched on the importance of increased awareness of milder forms of hypercortisolism, the challenges of diagnosing subtle endocrine disorders, and the critical impact of AI on data analysis and patient identification.

New osilodrostat data in adrenal Cushing’s

August 5, 2026

From Lewis Blevins, M.D. Medical Director of the California Center for Pituitary Disorders at UCSF and PWN co-founder – a summary of an important study by Dr. Marta Araujo-Castro and others (J Clin Endocrinol Metab 111:2180-2189, 2026) recently published a manuscript titled “International real-world study on osilodrostat efficacy and safety in adrenal Cushing syndrome.”

Adrenal Cushing’s: a conversation

October 1, 2025

Listen to this fascinating discussion of adrenal Cushing’s or hypercortisolism as Dr. Lewis Blevins walks us through the disease’s characteristics, biochemistry, and treatment options. In the talk, he focuses on different conditions, including adrenal adenomas, adrenal cancer, adrenal hyperplasia, and other related diseases like Carney Complex and McCune-Albright syndrome.